Avalo Therapeutics Inc. (AVTX) Revenue and Competitors
Estimated Revenue & Valuation
- Avalo Therapeutics Inc. (AVTX)'s estimated annual revenue is currently $5M per year.
- Avalo Therapeutics Inc. (AVTX)'s estimated revenue per employee is $155,000
Employee Data
- Avalo Therapeutics Inc. (AVTX) has 32 Employees.
- Avalo Therapeutics Inc. (AVTX) grew their employee count by 0% last year.
Avalo Therapeutics Inc. (AVTX)'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP CMC Biologics | Reveal Email/Phone |
2 | VP, Head IT/IS | Reveal Email/Phone |
3 | VP CMC Biologics | Reveal Email/Phone |
4 | Head Administration | Reveal Email/Phone |
5 | VP, Corporate Controller | Reveal Email/Phone |
6 | SVP, Program Management and Corporate Infrastructure | Reveal Email/Phone |
7 | SVP, Global Regulatory Affairs and Quality Assurance | Reveal Email/Phone |
8 | Sr Director, Project Management | Reveal Email/Phone |
9 | Senior Director Quality Assurance | Reveal Email/Phone |
10 | Chief Financial Officer at Avalo Therapeutics | Reveal Email/Phone |
Avalo Therapeutics Inc. (AVTX) Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Avalo Therapeutics Inc. (AVTX)?
N/A
Total Funding
32
Number of Employees
$5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Avalo Therapeutics Inc. (AVTX) News
2022-04-17 - Is Avalo Therapeutics Inc (AVTX) a Stock to Watch After Losing -3.08% This Week?
AVTX receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator. Sentiment Score - ,bearish. Avalo Therapeutics Inc has a...
2022-04-17 - Zacks: Analysts Expect Avalo Therapeutics, Inc. (NASDAQ:AVTX ...
Zacks: Analysts Expect Avalo Therapeutics, Inc. (NASDAQ:AVTX) Will Announce Earnings of -$0.14 Per Share. Posted by admin on Apr 18th, 2022.
2022-04-06 - Should You Buy Avalo Therapeutics Inc (AVTX) Stock on Wednesday?
AVTX gets a Neutral score from InvestorsObserver Stock Sentiment Indicator. Sentiment Score - ,neutral. Avalo Therapeutics Inc has a Neutral...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.2M | 32 | -18% | N/A |
#2 | $3.7M | 32 | N/A | N/A |
#3 | $3.7M | 32 | N/A | N/A |
#4 | $6.4M | 32 | N/A | N/A |
#5 | $3.7M | 32 | N/A | N/A |